Mutations in the insulin receptor gene

Endocrine Reviews

Volumn 13, Issue 3, 1992, Pages 566-595

  Taylor, Simeon I ^a   Cama, Alessandro ^a   Accili, Domenico ^a   Barbetti, Fabrizio ^a   Quon, Michael J ^a   Sierra, Maria De La Luz ^a   Suzuki, Yoshifumi ^a   Roller, Elizabeth ^a   Levy toledano, Rachel ^a   Wertheimer, Efrat ^a   Moncadaj, Victoria Y ^a   Kadowaki, Hiroko ^a   Kadowaki, Takashi ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE;

ALLELE; ENDOCYTOSIS; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HOMOZYGOSITY; HUMAN; INSULIN BINDING; INSULIN RESISTANCE; INTRACELLULAR TRANSPORT; LEPRECHAUNISM; LIPODYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; HUMAN; INSULIN; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN-TYROSINE KINASE; RECEPTOR, INSULIN; SYNDROME;

EID: 0026761432     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-13-3-566     Document Type: Article

References (195)

1. Freychet P, Roth J, Neville Jr DM 1971 Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. Biochem Biophys Res Commun 43:400-408
2. 125I] insulin to the plasma membrane and its relation to insulin bioactivity. Proc Natl Acad Sci USA 68:1833-1877
3. Cuatrecasas P 1971 Insulin-receptor interactions in adipose tissue cells: direct measurement properties. Proc Natl Acad Sci USA 68:1264-1268
4. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J 1985 Human insulin receptor, its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-761
5. Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, Ou JH, Masiarz F, Kan YW, Goldfine ID, Roth RA, Rutter WJ 1985 The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40:747-758
6. Taylor SI, Kadowaki T, Kadowaki H, Accili D, Cama A, McKeonC 1990 Mutations in the insulin receptor gene in insulin resistant patients. Diabetes Care 13:13257-279
7. Taylor SI, Kadowaki T, Accili D, Cama A, Kadowaki H, McKeon C, Moncada V, Marcus-Samuels B, Bevins C, Ojamaa K, Frapier Beitz L, Perrotti N, Rees-Jones R, Margolis R, Gorden P, Roth J 1990 Mutations in the insulin receptor gene in genetic forms of insulin resistance. Recent Prog Horm Res 46:185-217
8. Kasuga M, Karlsson FA, Kahn CR 1982 Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215:185-187
9. Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR 1982 Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298:667-669
10. Rosen OM 1987 After insulin binds. Science 237:1452-1458
11. Seino S, Seino M, Nishi S, Bell GI 1989 Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci USA 86:114-118
12. Yang-Feng TL, Francke U, Ullrich A 1985 Gene for human insulin receptor: localization to site on chromosome 19 involved in pre-B-cell leukemia. Science 228:728-731
13. Araki E, Shimada F, Uzawa H, Mori M, Ebina Y 1987 Characterization of the promoter region of the human insulin receptor gene. J Biol Chem 262:16186-16191
14. Mamula PW, Wong KY, Maddux BA, McDonald AR, Goldfine ID 1988 Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes 37:1241-1246
15. Tewari DS, Cook DM, Taub R 1989 Characterization of the promoter region and 3’-end of the human insulin receptor gene. J Biol Chem 264:16238-16245
16. McKeon C, Moncada V, Pham T, Salvatore P, Kadowaki T, Accili Taylor SI 1990 Structural and functional analysis of the insulin receptor promoter. Mol Endocrinol 4:647-656
17. McKeon C, Pham T 1991 Transactivation of the human insulin receptor gene by the CAAT/enhancer binding protein. Biochem Biophys Res Commun 174:721-728
18. Goldstein BJ, Kahn CR 1989 Analysis of mRNA heterogeneity by ribonuclease H mapping: application to the insulin receptor. Biochem Biophys Res Commun 159:664-669
19. Seino S, Bell GI 1989 Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 159:312-316
20. Moller DE, Yokota A, Caro JF, Flier JS 1989 Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3:1263-1269
21. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA 1990 Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 9:2409-2413
22. Kadowaki T, Kadowaki H, Taylor SI 1990 A nonsense mutation causing decreased levels of insulin receptor mRNA: Detection by a simplified technique for direct sequencing of genomic DNA amplified by polymerase chain reaction. Proc Natl Acad Sci USA 87:658-662
23. Kadowaki T, Kadowaki H, Rechler MM, Serrano-Rios M, Roth J, Gorden P, Taylor SI 1990 Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. J Clin Invest 86:254-264
24. Kusari J, Takata Y, Hatada E, Friedenberg G, Kolterman O, Olefsky JM 1991 Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles. J Biol Chem 266:5260-5267
25. Kadowaki T, Kadowaki H, Ando A, Kaburagi Y, Quin JD, MacCuish A, Taylor SI, Yazaki Y, Kasuga M, Two mutant alleles of the insulin receptor gene in insulin resistant patients. Program and Abstracts of the 73rd Annual Meeting of The Endocrine Society, Washington, D.C., 1991, p 310 (abstract 1119)
26. Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, Beitz L, McKeon C, Taylor SI 1988 Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240:787-790
27. Taira M, Taira M, Hashimoto N, Shimada F, Suzuki Y, Kanat-suka A, Nakamura F, Ebina Y, Tatibana M, Makino H, Yoshida S 1989 Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor. Science 245:63-6628
28. Shimada F, Taira M, Suzuki Y, Hashimoto N, Nozaki O, Taira M, Tatibana M, Ebina Y, Tawata M, Onaya T, Makino H, Yoshida S 1990 Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene. Lancet 335:1179-1181
29. Matsuura N, Tonoki H, Okuno A, Fujieda K 1991 A case of leprechaunism: its insulin-receptor gene analysis. Diabetes 40 [Suppl 1]:113A (abstract 450)
30. Wertheimer E, Litvin Y, Ebstein RP, Bennett ER, Barbetti F, Accili D, Taylor SI 1992 An insulin receptor gene deletion in a kindred with a familial form of insulin resistance. Diabetologia, in press
31. Imano E, Kadowaki H, Kadowaki T, Iwama N, Watarai T, Ka-wamori R, Kamada T, Taylor SI 1991 Two patients with insulin resistance due to decreased levels of insulin receptor mRNA. Diabetes 40:548-557
32. Ojamaa K, Hedo JA, Roberts Jr CT, Gorden P, Ullrich A, Taylor SI 1988 Defects in human insulin receptor gene expression. Mol Endocrinol 2:242-247
33. Bajaj M, Waterfield MD, Schlessinger J, Taylor WR, Blundell T 1987 On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors. Biochim Biophys Acta 916:220-226
34. van der Vorm ER, van der Zon GCM, Möller W, Krans HMJ, Lindhout D, Maassen JA 1992 An Arg for Gly substitution at position 31 in the insulin receptor, linked to insulin resistance, inhibits receptor processing and transport. J Biol Chem 267:6671
35. Barbetti F, Gejman PV, Taylor SI, Raben N, Cama A, Bonora E, Pizzo P, Moghetti P, Muggeo M, Roth J 1992 Detection of mutations in the insulin receptor gene by denaturing gradient gel electrophoresis. Diabetes 41:408-415
36. Andersen AS, Kjeldsen T, Wiberg FC, Christensen PM, Rasmussen JS, Norris K, Möller KB, Möller NPH 1990 Changing the insulin receptor to possess insulin-like growth factor I ligand specificity. Biochemistry 29: 7363-7366
37. Kjeldsen T, Andersen AS, Wiberg FC, Rasmussen JS, Schaffer L, Baischmidt P, Möller KB, Möller NPH 1991 The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. Proc Natl Acad Sci USA 88:4404-4408
38. Gustafson TA, Rutter WJ 1990 The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. J Biol Chem 265:18663-18667
39. Schaefer EM, Siddle K, Ellis L 1990 Deletion analysis of the human insulin receptor ectodomain reveals independently folded soluble subdomains and insulin binding by a monomeric a-sub-unit. J Biol Chem 265:13248-13253
40. Zhang B, Roth RA 1991 Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor. Biochemistry 30:5113-5117
41. Zhang B, Roth RA 1991 A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients’ autoimmune antibodies and inhibitory monoclonal antibodies. Proc Natl Acad Sci USA 88:9858-9862
42. Schumacher R, Mosthaf L, Schlessinger J, Brandenburg D, Ullrich A 1991 Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. J Biol Chem 266:19288-19295
43. Kadowaki T, Kadowaki H, Accili D, Yazaki Y, Taylor SI 1991 Substitution of arginine for histidine at position 209 in the a-subunit of the human insulin receptor. A mutation that impairs receptor dimerization and transport of receptors to the cell surface. J Biol Chem 266:21224-21231
44. Kadowaki H, Kadowaki T, Cama A, Marcus-Samuels B, Rovira A, Bevins C, Taylor SI 1990 Mutagenesis of lysine-460 in the human insulin receptor: effects upon receptor recycling and sitesite interactions among binding sites. J Biol Chem 265:21285-21296
45. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA 1990 Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 9:2409-2413
46. McClain DA 1991 Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 5:734-739
47. Yamaguchi Y, Flier JS, Yokota A, Benecke H, Backer JM, Moller DE 1991 Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 129:2058-2066
48. Yoshimasa Y, Paul JI, Whittaker J, Steiner DF 1990 Effects of amino acid replacements within the tetrabasic cleavage site on the processing of the human insulin receptor precursor expressed in Chinese hamster ovary cells. J Biol Chem 265:17230-17237
49. Williams JF, McClain DA, Dull TJ, Ullrich A, Olefsky JM 1990 Characterization of an insulin receptor mutant lacking the subunit processing site. J Biol Chem 265:8463-8469
50. Collier E, Gorden P 1991 O-linked oligosaccharides on insulin receptor. Diabetes 40:197-203
51. Thies RS, Webster NJ, McClain DA 1990 A domain of the insulin receptor required for endocytosis in rat fibroblasts. J Biol Chem 265:10132-10137
52. Rajagopalan M, Neidigh JL, McClain DA 1991 Amino acid sequences Gly-Pro-Leu-Tyr and Asn-Pro-Gly-Tyr in the submem-branous domain of the insulin receptor are required for normal endocytosis. J Biol Chem 266:23068-23073
53. Backer JM, Kahn CR, Cahill DA, Ullrich A, White MF 1990 Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit. J Biol Chem 265:16450-16454
54. Berhanu P, Ibrahim-Schneck RH, Anderson C, Wood WM 1991 The NPEY sequence is not necessary for endocytosis and processing of insulin-receptor complexes. Mol Endocrinol 5:1827-1835
55. White MF, Livingston JN, Backer JM, Lauris V, Dull TJ, Ullrich A, Kahn CR 1988 Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54:641-649
56. Hanks SK, Quinn AM, Hunter T 1988 The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42-52
57. Odawara M, Kadowaki T, Yamamoto R, Shibasaki Y, Tobe K, Accili D, Bevins C, Mikami Y, Matsuura N, Akanuma Y, Takaku F, Taylor SI, Kasuga M 1989 Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science 245:66-68
58. Chou CK, Dull TJ, Russell DS, Gherzi R, Lebwohl D, Ullrich A, Rosen OM 1987 Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J Biol Chem 262:1842-18447
59. Ebina Y, Araki E, Taira M, Shimada F, Mori M, Craik CS, Siddle K, Pierce SB, Roth RA, Rutter WJ 1987 Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin-and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci USA 84:704-708
60. McClain DA, Maegawa H, Lee J, Dull TJ, Ullrich A, Olefsky JM 1987 A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem 262:14663-14671
61. Tornqvist HE, Pierce MW, Frackelton HR, Nemenoff RA, Avruch J 1987 Identification of the insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem 262:10212-10219
62. Tornqvist HE, Gunsalus JR, Nemenoff RA, Frackelton HR, Pierce MW, Avruch J 1988 Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells. J Biol Chem 263:350-359
63. Tornqvist HE, Avruch J 1988 Relationship of site-specific beta subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase. J Biol Chem 263:4593-4601
64. Tavare JM, O’Brien RM, Siddle K, Denton RM 1988 Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping. Biochem J 253:783-788
65. Flores-Riveros JR, Sibley E, Kastelic T, Lane MD 1989 Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. J Biol Chem 264:21557-21572
66. White MF, Shoelson SE, Keutmann H, Kahn CR 1988 A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 263:2969-2980
67. Herrera R, Rosen OM 1986 Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation. J Biol Chem 261:11980-11985
68. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512
69. Koshio O, Akanuma Y, Kasuga M 1989 Identification of a phosphorylation site of the rat insulin receptor catalyzed by protein kinase C in an intact cell. FEBS Lett 254:22-24
70. Lewis RE, Cao L, Perregaux D, Czech MP 1990 Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. Biochemistry 29:1807-1813
71. Lewis RE, Wu GP, MacDonald RG, Czech MP 1990 Insulinsensitive phosphorylation of serine 1293/1294 on the human insulin receptor by a tightly associated serine kinase. J Biol Chem 265:947-954
72. Hedo JA, Kasuga M, Van Obberghen E, Roth J, Kahn CR 1981 Direct demonstration of glycosylation of insulin receptor subunits by biosynthetic and external labeling: evidence for heterogeneity. Proc Natl Acad Sci USA 78:4791-4795
73. Hedo JA, Kahn CR, Hayashi M, Yamada KM, Kasuga M 1983 Biosynthesis and glycosylation of the insulin receptor. Evidence for a single polypeptide precursor of the two major subunits. J Biol Chem 258:10020-10026
74. Ronnett GV, Knutson VP, Kohanski RA, Simpson TL, Lane MD 1984 Role of glycosylation in the processing of newly translated insulin proreceptor in 3T3-L1 adipocytes. J Biol Chem 259:4566-4575
75. Deutsch PJ, Wan CF, Rosen OM, Rubin CS 1983 Latent insulin receptors and possible receptor precursors in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 80:133-136
76. Jacobs SJ, Kull FCJ, Cuatrecasas P 1983 Monensin blocks the maturation of receptors for insulin and somatomedin C: identification of receptor precursors. Proc Natl Acad Sci USA 80:1228-1231
77. Olson TS, Bamberger MJ, Lane MD 1988 Post-translational changes in tertiary and quaternary structure of the insulin proreceptor. Correlation with acquisition of function. J Biol Chem 263:7342-7351
78. Kadowaki T, Kadowaki H, Accili D, Taylor SI 1990 Substitution of lysine for asparagine-15 in the human insulin receptor impairs intracellular transport of the receptor to the cell surface and decreases the affinity of insulin binding. J Biol Chem 265:19143-19150
79. Herzberg VL, Grigorescu F, Edge AS, Spiro RG, Kahn CR 1985 Characterization of insulin receptor carbohydrate by comparison of chemical and enzymatic deglycosylation. Biochem Biophys Res Commun 129:789-796
80. Hedo JA, Collier E, Watkinson A 1987 Myristyl and palmityl acylation of the insulin receptor. J Biol Chem 262:954-957
81. Yoshimasa Y, Seino S, Whittaker J, Kakehi T, Kosaki A, Kuzuya H, Imura I, Bell GI, Steiner DF 1988 Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science 240:784-787
82. Kobayashi M, Sasaoka T, Takata Y, Hisatomi A, Shigeta Y 1988 Insulin resistance by unprocessed insulin proreceptors point mutation at the cleavage site. Biochem Biophys Res Commun 153:657-663
83. Accili D, Frapier C, Mosthaf L, McKeon C, Elbein SC, Permutt E, Ramos E, Lander E, Ullrich A, Taylor SI 1989 A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin resistant diabetes. EMBO J 8:2509-2517
84. Kakehi T, Hisatomi A, Kuzuya H, Yoshimasa Y, Okamoto M, Yamada K, Nishimura H, Kosaki A, Nawata H, Umeda F, Ibay-ashi H, Imura H 1988 Defective processing of insulin receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance. J Clin Invest 81:2020-2022
85. Kobayashi M, Sasaoka T, Takata Y, Hisatomi A, Shigeta Y 1988 Insulin resistance by uncleaved insulin proreceptor. Emergence of binding site by trypsin. Diabetes 37:653-656
86. Klinkhamer M, Groen NA, van der Zon GCM, Lindhout D, Sandkuyl LA, Krans HM, Moller W, Maassen JA 1989 A leucine-toproline mutation in the insulin receptor in a family with insulin resistance. EMBO J 8:2503-2507
87. Maassen JA, Van der Vorm ER, Van der Zon GCM, Klinkhamer MP, Krans HM, Moller W 1991 A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface. Biochemistry 30:10778-10783
88. Accili D, Kadowaki T, Kadowaki H, Mosthaf L, Ullrich A, Taylor SI 1992 Immunoglobulin heavy chain binding protein (BiP) binds to misfolded mutant insulin receptors with mutations in the extracellular domain. J Biol Chem 267:586-590
89. Pelham HRB 1989 Control of protein exit from the endoplasmic reticulum. Annu Rev Cell Biol 5:1-23
90. Accili D, Mosthaf L, Ullrich A, Taylor SI 1991 A mutation in the extracellular domain of the insulin receptor impairs the ability of insulin to stimulate receptor autophosphorylation. J Biol Chem 266:434-439
91. Waelbroeck M, Van Obberghen E, De Meyts P 1979 Thermodynamics of the interaction of insulin with its receptor. J Biol Chem 254:7736-7740
92. Waelbroeck M 1979 The pH dependence of insulin binding. A quantitative study. J Biol Chem 257:8284-8291
93. Klotz IM, Hunston DL 1971 Properties of graphical representations of multiple classes of binding sites. Biochemistry 10:3065-3069
94. Kahn CR, Freychet P, Roth J, Neville DM Jr 1974 Quantitative aspects of the insulin-receptor interaction in liver plasma membranes. J Biol Chem 249:2249-2257
95. De Meyts P, Roth J 1975 Cooperativity in ligand binding: a new graphic analysis. Biochem Biophys Res Commun 66:1118-1126
96. De Meyts P, Bianco AR, Roth J 1976 Site-site interactions among insulin receptors. Characterization of the negative cooperativity. J Biol Chem 251:1877-1888
97. Wang C-C, Goldfine ID, Fumita-Yamaguchi Y, Gattner HG, Brandenburg D, De Meyts P 1988 Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor. Proc Natl Acad Sci USA 85:8400-8404
98. Boni-Schnetzler M, Scott W, Waugh SM, DiBella E, Pilch PF 1987 The insulin receptor. Structural basis for high affinity ligand binding. J Biol Chem 262:8395-8340
99. 2 heterotetrameric insulin receptor complex. A structural basis for insulin binding heterogeneity. J Biol Chem 262:6939-6942
100. Bayne ML, Applebaum J, Underwood D, Chicchi GG, Green BG, Hayes NS, Cascieri MA 1989 The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor. J Biol Chem 264:11004-11008
101. Taylor SI, Roth J, Blizzard RM, Elders MJ 1981 Qualitative abnormalities in insulin binding in a patient with extreme insulin resistance: Decreased sensitivity to alterations in temperature and pH. Proc Natl Acad Sci USA 78:7157-7161
102. Morgan DO, Ho L, Korn LJ, Roth RA 1986 Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci USA 83:328-332
103. Morgan DO, Roth RA 1987 Acute insulin action requires insulin receptor kinase acitivty: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin. Proc Natl Acad Sci USA 84:41-45
104. Cama A, Sierra ML, Ottini L, Kadowaki T, Gorden P, Imperato-McGinley J, Taylor SI 1991 A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocrinol Metab 73:894-901
105. Cama A, Quon MJ, Sierra ML, Taylor SI 1992 Substitution of isoleucine for methionine at position 1153 in the β-subunit of the human insulin receptor. J Biol Chem 267:8383-8389
106. Cama A, Sierra ML, Ottini L, Gorden P, Taylor SI, Mutation in the tyrosine kinase domain of the insulin receptor gene in a patient with insulin resistance, acanthosis nigricans, and hyper-androgenism. Program and Abstracts of the 73rd Annual Meeting of The Endocrine Society, Washington, D.C., 1991, p 466 (abstract 1741)
107. Moller DE, Flier JS 1988 Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance). N Engl J Med 319:1526-1529
108. 1200 mutation of the insulin receptor. Mol Endocrinol 4:1183-1191
109. 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J Biol Chem 265:14979-14985
110. Forsayeth JR, Caro JF, Sinha MK, Maddux BA, Goldfine ID 1987 Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity. Proc Natl Acad Sci USA 84:3448-3451
111. Hawley DM, Maddux BA, Patel RG, Wong KY, Mamula PW, Firestone GL, Brunetti A, Verspohl E, Goldfine ID 1989 Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase. J Biol Chem 264:2438-2444
112. Brunetti A, Maddux BA, Wong KY, Hofmann C, Whittaker J, Sung C, Goldfine ID 1989 Monoclonal antibodies to the human insulin receptor mimic a spectrum of biological effects in transfected 3T3/HIR fibroblasts without activating receptor kinase. Biochem Biophys Res Commun 165:212-218
113. Soos MA, O’Brien RM, Brindle NPJ, Stigter JM, Okamoto AK, Whittaker J, Siddle K 1989 Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblasts. Proc Natl Acad Sci USA 86:5217-5221
114. Gherzi R, Russell DS, Taylor SI, Rosen OM 1987 Réévaluation of the evidence that an antibody to the insulin receptor is insulinmimetic without activating the protein tyrosine kinase activity of the receptor. J Biol Chem 262:16900-16905
115. Steele-Perkins G, Roth RA 1990 Insulin-mimetic anti-insulin receptor monoclonal antibodies stimulate receptor kinase activity in intact cells. J Biol Chem 265:9458-9463
116. Kono T, Barham FW 1971 The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin. J Biol Chem 246:6210-6216
117. Shoelson SE, White MF, Kahn CR 1988 Tryptic activation of the insulin receptor. Proteolytic truncation of the α-subunit releases the β-subunit from inhibitory control. J Biol Chem 263:2852-2860
118. Ellis L, Morgan DO, Clauser E, Roth RA, Rutter WJ 1987 A membrane-anchored cytoplasmic domain of the human insulin receptor mediates a constitutively elevated insulin-independent uptake of 2-deoxyglucose. Mol Endocrinol 1:15-24
119. Bôni-Schnetzler M, Rubin JB, Pilch PF 1986 Structural requirements for the transmembrane activation of the insulin receptor kinase. J Biol Chem 261:15281-15287
120. Bôni-Schnetzler M, Rubin JB, Pilch PF 1986 Structural requirements for the transmembrane activation of the insulin receptor kinase. J Biol Chem 261:15281-15287
121. Boni-Schnetzler M, Kaligian A, DelVecchio R, Pilch PF 1988 Ligand-dependent intersubunit association within the insulin receptor complex activates its intrinsic kinase activity. J Biol Chem 263:6822-6828
122. Sweet LJ, Morrison BD, Wilden PA, Pessin JE 1987 Insulindependent intermolecular subunit communication between isolated αβ heterodimeric insulin receptor complexes. J Biol Chem 262:16730-16738
123. 2 heterotetrameric disulfide-linked complex. J Biol Chem 263:7806-7813
124. 2 heterotetrameric state. Biochemistry 28:785-792
125. Whittaker J, Okamoto A 1988 Secretion of soluble functional insulin receptors by transfected NIH3T3 cells. J Biol Chem 263:3063-3066
126. Johnson JD, Wong ML, Rutter WJ 1988 Properties of the insulin receptor ectodomain. Proc Natl Acad Sci USA 85:7516-7520
127. Yarden Y, Ullrich A 1988 Growth factor receptor tyrosine kinases. Annu Rev Biochem 57:443-478
128. Herrera R, Petruzelli L, Thomas N, Bramson HN, Kaiser ET, Rosen OM 1985 An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity. Proc Natl Acad Sci USA 82:7899-7903
129. Baron V, Gautier N, Komoriya A, Hainaut P, Scimeca JC, Mervic M, Lavielle S, Dolais-Kitabgi J, Van Obberghen E 1990 Insulin binding to its receptor induces a conformational change in the receptor C-terminus. Biochemistry 29:4634-4641
130. Perlman R, Bottaro DP, White MF, Kahn CR 1989 Conformational changes in the alpha-and beta-subunits of the insulin receptor identified by anti-peptide antibodies. J Biol Chem 264:8946-8950
131. Maddux BA, Goldfine ID 1991 Evidence that insulin plus ATP may induce a conformational change in the beta subunit of the insulin receptor without inducing receptor autophosphorylation. J Biol Chem 266:6731-6736
132. Ridge KD, Hofmann K, Finn FM 1988 ATP sensitizes the insulin receptor to insulin. Proc Natl Acad Sci USA 85:9489-9493
133. r-185,000 protein in intact cells. Nature 318:183-186
134. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF 1991 Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77
135. Chen WJ, Goldstein JL, Brown MS 1990 NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J Biol Chem 265:3116-3123
136. Ellis L, Clauser E, Morgan DO, Edery M, Roth RA, Rutter WJ 1986 Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45:721-732
137. Debant A, Clauser E, Ponzio G, Filloux A, Auzari C, Confreres JO, Rossi B 1988 Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci USA 85:8032-8036
138. Wilden PA, Backer JM, Kahn CR, Cahill DA, Schroeder GJ, White MF 1990 The insulin receptor with phenylalanine replacing tyrosine-1146 provides evidence for separate signals regulating cellular metabolism and growth. Proc Natl Acad Sci USA 87:3358-3362
139. Rafaeloff R, Maddux BA, Brunetti A, Sbraccia P, Sung CK, Patel R, Hawley DM, Goldfine ID 1991 Transmembrane signalling by insulin via an insulin receptor mutated at tyrosines 1158, 1162, and 1163. Biochem Biophys Res Commun 179:912-918
140. Yonezawa K, Roth RA 1991 Assessment of the in situ tyrosine kinase activity of mutant insulin receptors lacking tyrosine autophosphorylation sites 1162 and 1163. Mol Endocrinol 5:194-200
141. Zhang B, Tavare JM, Ellis L, Roth RA 1991 The regulatory role of known tyrosine autophosphorylation sites of the insulin receptor kinase domain. An assessment by replacement with neutral and negatively charged amino acids. J Biol Chem 266:990-996
142. Murakami MS, Rosen OM 1991 The role of insulin receptor autophosphorylation in signal transduction. J Biol Chem 266:22653-22660
143. McClain DA, Maegawa H, Levy J, Huecksteadt T, Dull TJ, Lee J, Ullrich A, Olefsky JM 1988 Properties of a human insulin receptor with a C terminal truncation. I. Insulin binding, autophosphorylation and endocytosis. J Biol Chem 263:8904-8911
144. Maegawa H, McClain DA, Freidenberg G, Olefsky JM, Napier M, Lipart T, Dull TJ, Lee J, Ullrich A 1988 Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic events. J Biol Chem 263:8912-8917
145. Thies RS, Ullrich A, McClain DA 1989 Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor. J Biol Chem 264:12820-12825
146. Myers MG, Backer JM, Siddle K, White MF 1991 The insulin receptor functions normally in Chinese hamster ovary cells after truncation of the C terminus. J Biol Chem 266:10616-23
147. O’Rahilly S, Choi W H Patel P, Turner RC, Flier JS, Moller DE 1991 Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes 40:777-782
148. Kusari J, Takata Y, Hatada E, Freidenberg G, Kolterman O, Olefsky JM 1991 Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles. J Biol Chem 266:5260-5267
149. Cocozza S, Porcellini A, Riccardi G, Monticelli A, Condorelli G, Ferrara A, Pianese L, Miele C, Capaldo B, Beguinot F, Varrone S 1992 NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes 41:521-526
150. Kim H, Kadowaki H, Sakura H, Momomura K, Takahashi Y, Miyazaki Y, Ohtani T, Akanuma Y, Yazaki Y, Kasuga M, Taylor SI, Kadowaki T 1992 Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single stranded conformational polymorphisms. Diabetologia 35: 261-266
151. Grunberger G, Zick Y, Gorden P 1984 Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient with normal insulin binding. Science 223:932-934
152. Roach P, Arakaki RF, Accili D, Taylor SI, Gorden P 1992 Extreme insulin resistance associated with decreased tyrosine kinase activity: mutation in the insulin receptor β-subunit. Clin Res. 40:311 A (abstract)
153. Treadway JL, Morrison BD, Soos MA, Siddle K, Olefsky J, Ullrich A, McClain DA, Pessin JE 1991 Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci USA 88:214-218
154. 996. J Biol Chem 265:14777-14783
155. Moller DE, Benecke H, Flier JS 1991 Biologic activities of naturally occurring human insulin receptor mutations. Evidence that metabolic effects of insulin can be mediated by a kinase-deficient insulin receptor mutant. J Biol Chem 266:10995-11001
156. Carpentier JL, Paccaud JP, Gorden P, Rutter WJ, Orci L 1992 Insulin-induced surface redistribution regulates internalization of the insulin receptor and requires its autophosphorylation. Proc Natl Acad Sci USA 89:162-166
157. Yamamoto T, Bishop RW, Brown MS, Goldstein JL, Russell DW 1986 Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. Science 232:1230-1237
158. Flier JS, Minaker KL, Landsberg L, Young JB, Pallotta J, Rowe JW 1982 Impaired in vivo insulin clearance in patients with severe target-cell resistance to insulin. Diabetes 31:132-135
159. Sodoyez JC, Sodoyez-Goffaux F, Treves S, Kahn CR, von Frenck-ell R 1984 In vivo imaging and quantitative analysis of insulin-receptor interaction in lean and obese Zucker rats. Diabetologia 26:229-233
160. Maratos-Flier E, Kao CY, Verdin EM, King GL 1987 Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells. J Cell Biol 105:1595-1601
161. Gavin III JR, Roth J, Neville Jr DM, De Meyts P, Buell DN 1974 Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci USA 71:84-88
162. Kasuga M, Kahn CR, Hedo JA, Van Obberghen E, Yamada KM 1978 Insulin-induced receptor loss in cultured human lymphocytes is due to accelerated receptor degradation. Proc Natl Acad Sci USA 78:6917-6921
163. Russell DS, Gherzi R, Johnson EL, Chou CK, Rosen OM 1987 The protein-tyrosine kinase activity of the insulin receptor is necessary for insulin-mediated receptor down-regulation. J Biol Chem 262:11833-11840
164. Backer JM, Shoelson SE, Haring E, White MF 1991 Insulin receptors internalize by a rapid saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region. J Ceil Biol 115:1535-1545
165. Bar RS, Muggeo M, Roth J, Kahn CR, Havrankova J, Imperato-McGinley J 1978 Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: evidence for a postreceptor defect. J Clin Endocrinol Metab 47:620-625
166. Elders MJ, Schedewie HK, Olefsky J, Givens B, Char F, Bier DM, Baldwin D, Fiser RH, Seyedabadi S, Rubenstein A 1982 Endocrine-metabolic relationships in patients with leprechaunism. J Natl Med Assoc 74:1195-1210
167. Taylor SI, Marcus-Samuels B, Ryan-Young J, Leventhal S, Elders MJ 1986 Genetics of the insulin receptor defect in a patient with extreme insulin resistance. J Clin Endocrinol Metab 62:1130-1135
168. McElduff A, Hedo JA, Taylor SI, Roth J, Gorden P 1984 Mechanisms responsible for the decreased concentration of insulin receptors in cultured cells from patients with genetic forms of extreme insulin resistance. Clin Invest 74:1366-1374
169. Taylor SI, Leventhal S 1983 Defect in cooperativity in insulin receptors from a patient with a congenital form of extreme insulin resistance. J Clin Invest 71:1676-1685
170. Davis CG, Goldstein JL, Sudhof TC, Anderson RG, Russell DW, Brown MS 1987 Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region. Nature 326:760-765
171. Cama A, Sierra ML, Taylor SI, Detection of a mutation substituting asparagine for serine at codon 462 in the insulin receptor gene in a second kindred with a genetic form of insulin resistance. Program and Abstracts of the 74th Annual Meeting of The Endocrine Society, San Antonio, Texas, 1992, p. 61 (abstract 39)
172. Rosenberg AM, Haworth JC, Degroot GW, Trevanen CL, Rechler MM: 1980 A case of leprechaunism with severe hyperinsulinemia. Am J Dis Child 134:170-175
173. Suzuki Y, Hatanaka Y, Shimada F, Nozaki O, Takayanagi M, Makino H, Yoshida S 1992 Insulin resistance associated with decreased levels of insulin receptor mRNA Diabetes, 41 [Suppl 1]: 90A (abstract 325)
174. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J 1976 The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 294:739-745
175. Fradkin JE, Eastman RC, Lesniak MA, Roth J 1989 Specificity spillover at the hormone receptor—exploring its role in human disease. N Engl J Med 320:640-645
176. Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, MacCuish AC 1990 Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall’s syndrome [letter]. N Engl J Med 323:1425-1426
177. Rabson SM, Mendenhall EN 1956 Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus. Am J Clin Pathol 26:283-290
178. West RJ, Leonard JV 1980 Familiar insulin resistance with pineal hyperplasia: metabolic studies and effects of hypophysectomy. Arch Dis Child 55:619-621
179. Yokota A, Moller DE, Flier JS 1990 Homozygous mutation at position 485 of the insulin receptor a-subunit in a patient with lipodystrophy and severe insulin resistance. Diabetes 39 [Suppl 1]:235A (abstract 911)
180. Kriauciunas KM, Kahn CR, Muller-Wieland D, Reddy SS, Taub R 1988 Altered expression and function of the insulin receptor in a family with lipoatrophic diabetes. J Clin Endocrinol Metab 67:1284-1293
181. Lekanne Deprez RH, Potter van Loon BJ, van der Zon GC, Möller W, Lindhout D, Klinkhamer MP, Krans HM, Maassen JA 1989 Individuals with only one allele for a functional insulin receptor have a tendency to hyperinsulinaemia but not to hyper-glycaemia. Diabetologia 32:740-744
182. Cama A, Patterson A, Kadowaki T, Siegel G, D’Ambrosio D, Lillioja S, Roth J, Taylor SI 1990 Cloning of insulin receptor cDNA from an insulin resistant Pima Indian. J Clin Endocrinol Metab 70:1155-1161
183. Moller DE, Yokota A, Flier JS 1989 Normal insulin-receptor cDNA sequence in Pima Indians with NIDDM. Diabetes 38:1496-1500
184. Kusari J, Verma US, Buse JB, Henry RR, Olefsky JM 1991 Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest 88:1323-1330
185. Kaplowitz PB, D’Ercole AJ 1982 Fibroblasts from a patient with leprechaunism are resistant to insulin, epidermal growth factor, and somatomedin C. J Clin Endocrinol Metab 55:741-748
186. Van Obberghen-Schilling EE, Rechler MM, Romanus JA, AB Knight AB, Nissley SP, Humbel RE 1981 Receptors for insulinlike growth factor I are defective in fibroblasts cultured from a patient with leprechaunism. J Clin Invest 68:1356-1365
187. Reddy SSK, Kahn CR 1989 Epidermal growth factor receptor defects in leprechaunism. A multiple growth factor-resistant syndrome. J Clin Invest 82:1359-1365
188. Rüdiger HW, Dreyer M, Kühnau J, Bartelheimer H 1983 Familial insulin-resistant diabetes secondary to an affinity defect of the insulin receptor. Hum Genet 64:407-411
189. Barnes ND, Palumbo PJ, Hayles AB, Folgar H 1974 Insulin resistance, skin changes, and virilization: a recessively inherited syndrome possibly due to pineal gland dysfunction. Diabetologia 10:285-289
190. Seino S, Seino M, Bell GI 1990 Human insulin receptor gene: partial sequence and amplification of exons using the polymerase chain reaction. Diabetes 39:123-128
191. Goldstein BJ, Kahn CR 1989 Insulin receptor messenger ribonucleic acid sequence alterations detected by ribonuclease cleavage in patients with syndromes of insulin resistance. J Clin Endocrinol Metab 69:15-24
192. Reddy SS-K, Lauris V, Kahn CR 1988 Insulin receptor function in fibroblasts from patients with leprechaunism. J Clin Invest 82:1359-1365
193. Brown MS, Goldstein JL 1986 A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
194. De Meyts P, Gu JL, Shymko RM, Kaplan BE, Bell GI, Whittaker J 1990 Identification of a ligand-binding region of the human insulin receptor encoded by the second exon of the gene. Mol Endocrinol 4:409-416
195. Taylor SI, Samuels B, Roth J, Kasuga M, Hedo JA, Gorden P, Brasel DE, Pokora T, Engel RR 1982 Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance. J Clin Endocrinol Metab 54:919-930